YuanBio Venture Capital — Full Portfolio
75 tracked investments · listed companies and verified rows first
Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.
BiotechHealthtechMedical Devices
Samantha DuinSamantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYajing Chen(Chief Financial Officer)inRafael G. Amado(President, Head of Global Research and Development)inF. Ty Edmondson(Chief Legal Officer)inJosh Smiley(President and Chief Operating Officer)
Co-investorsQiming Venture PartnersVivo CapitalAdvantech CapitalKleiner PerkinsSequoia Capital
MacroLux Medical Technology develops endoscopic imaging systems and related medical devices.
HardwareHealthtechMedical DevicesShenzhen, CN
Co-investorsDalton VentureLegend CapitalB Capital GroupB4 Capital
An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures Capital3H Health InvestmentSherpa Healthcare Partners
A pharmaceutical and life sciences company developing drug pipelines and conducting research and innovation activities.
BiotechHealthtechMedical DevicesShanghai, CN
Du JinhaoGuo Jianhui(Co-founder)
Co-investorsLAVLilly Asia Ventures
Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsDecheng CapitalQiming Venture Partners
Provider of R&D and one-stop production services to leading pharmaceutical companies worldwide.
Co-investorsHongShan Capital Group
A biopharmaceutical company developing CAR-T cell therapies for cancer treatment.
BiotechHealthtechMedical DevicesShanghai, CN
Co-investorsAcorn Pacific VenturesARCH Venture Partners
PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders.
BiotechHealthtechHangzhou, CN
Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.
BiotechDeep TechHardwareMedical Devices
Jeff Hawkins(CEO)inJeff Keyes(Chief Financial Officer)inChristian LaPointe(General Counsel)inTodd Rearick(Chief Technology Officer)inLindsay Thompson(Chief Human Resources Officer)in
Co-investorsForesite CapitalHighCape Capital
Shuwen Biotech develops molecular and immunodiagnostic products for women's health, including breast cancer subtyping kits, nucleic acid extraction systems, and point-of-care tests for pregnancy complications.
BiotechDigital HealthFemTechHealthtechMedical DevicesShanghai, CN
Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases.
BiotechHealthtechLongevityWaltham, US
Dr. Xiaodong Wang(Founder)Dr. Zhiyuan Zhang(Founder)
Co-investorsARCH Venture PartnersF-Prime CapitalCBC GroupEight Roads VenturesFuture InnovationGaorong Capital+5 more
TriApex provides contract research organization (CRO) services supporting pharmaceutical and biologics development, including preclinical studies, clinical trial design, regulatory strategy, and post-market safety monitoring.
BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesNanjing, CN
Co-investorsApricot Capital
Jiangsu Wanhe Technology Group is a custom software development service provider offering native app and mini-program development, e-commerce platform building, and high-end brand website design for business clients.
Developer ToolsE-commerceSaaSSuzhou, CN
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AIVFOAlltechAscentage PharmaATKCBasecare MedicalBeiGeneBeikang MedicalBestview LaserBGI Genomics (华大基因)BrightGeneCapitalbio TechnologyCF PharmTechCreative SciencesDami & XiaomiDeepCytoDymindEnzymasterFuture VisionGBSGenskeyH-BioHC SemiTekHengruiHengsheng MedicalHenlius BiotechiKangInnoModels BioInnoventiXINGJingfeng PharmaKangfu ZhijiaKangning HospitalKawin TechnologyKintor PharmaLegend CapitalLiferealLongwood ValleyNano-MicroNervtexNovaxelgenPanomixPharmacodiaPortenRainsureRongchang BioShengNuo BiotechSinobioway MedicineSINQISnibe DiagnosticSorrentoSunvouTigermedTongshu GeneUnionStrongUnited ImagingXABTXpeedic TechnologyYHLO BiotechZylox-Tonbridge
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











.jpeg)















